Next-Gen Delivery

Beyond Lipid Nanoparticles: The Search for Next-Generation Delivery Platforms

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

Pathfinder

Lipid Nanoparticles vs. Viral Vectors for Gene Delivery: Which Platform Is Better?

Pharma's Almanac

CRISPR

Integrated Capabilities Enable Faster Development of Effective CRISPR Therapies

Jessica Madigan; Amanda Haas

BIOVECTRA

LNPs

Expanding LNP Applications Beyond mRNA Vaccines

Jan Bekker; Phillip Elliott, Ph.D.; Jason Arcediano

BioCina

mRNA–LNP

Integrated mRNA–LNP Manufacturing as a Platform for Innovation

Jan Bekker

BioCina

Nanoparticles

How DIANT Pharma is Transforming Nanoparticle Manufacturing

Antonio Costa, Ph.D.

DIANT Pharma

Nanoscale

Addressing Drug Delivery Challenges at the Nanoscale

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Lipid Nanoparticles

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Jim Ziogas

DIANT Pharma

mRNA Innovations

Technology Advances Needed to Drive Future mRNA Growth

Hagen Richter, Ph.D.

Wacker Chemie AG

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Normand Blais; Jessica Madigan

BIOVECTRA

Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Lipid Nanoparticles

Lipid Nanoparticles: Transforming the Nanomedicines Market

Antonio Costa, Ph.D.

DIANT Pharma

Lipid Nanoparticle Development

Lipid Technology for Delivery of Gene-Editing Therapies

Stephen Burgess, Ph.D.

Croda Pharma

Quality by Design

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

Grant Henderson, Ph.D.; Lynda Menard, Ph.D.

Vernal Biosciences

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Sebastian Detlefsen, Dr.-Ing.; Rima Jaber, Ph.D.; Lauren Longobardi, Ph.D.

Evonik

Quality in mRNA Manufacturing

Quality in Equals Quality Out in mRNA Manufacturing

Judith McCorry

Vernal Biosciences